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Table 1
Groups of study.
Group Cells Scaffolds Culture Medium
I hBM-MSCs Col I Chondrogenic+100 nM PTHrP
II hBM-MSCs Col I + 1% HS Chondrogenic+100 nM PTHrP
III hBM-MSCs Col I + 2% HS Chondrogenic+100 nM PTHrP
IV hBM-MSCs Col I + 3% HS Chondrogenic+100 nM PTHrP
V hBM-MSCs Col I DMEM + 20% FBS+100 nM PTHrP
VI hBM-MSCs Col I + 1% HS DMEM + 20% FBS+100 nM PTHrP
VII hBM-MSCs Col I + 2% HS DMEM + 20% FBS+100 nM PTHrP
VIII hBM-MSCs Col I + 3% HS DMEM + 20% FBS+100 nM PTHrP
IX Chondrocytes Col I DMEM + 10% FBS+100 nM PTHrP
X Chondrocytes Col I + 1% HS DMEM + 10% FBS+100 nM PTHrP
XI Chondrocytes Col I + 2% HS DMEM + 10% FBS+100 nM PTHrP
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S271CD56+ cells and PDGFRa+ cells were isolated by using ﬂow cytometry and
the cells at fourth passage with 80% conﬂuence were collected and re-
suspended in a 15ml polypropylene tube containing 0.5 ml the chondro-
genic differentiation medium at a density of 5x105/ml, centrifuged at
200xg for 5min into cell mass. The cell mass were cultured at 37C in
a humidiﬁed atmosphere containing 5% carbon dioxide for 21 days with
the medium changes twice a week. After the morphological analysis of the
cell mass were performed for 21 day, the cell mass was ﬁxed with 4%
paraformaldehyde at room temperature, frozen and sectioned (6mm-
thick). The section was stained with toluidine blue.
Results: Cartilage-like tissue was not morphologically obtained by the cell
culturewith CD56+ cells, while successful formation of cartilage-like tissue
was achieved by the cell culture with PDGFRa+ cells. Moreover, patho-
logical examination demonstrated that toluidine blue was positive at the
marginal area of the section with PDGFRa+ cells, while toluidine blue-
positive cells of the pathological section with CD56+ cells were not
apparently observed in the section with PDGFRa+ cells.
Conclusions: PDGFRa+ cells seem to be suitable for cartilage formation in
vitro; however, it seems that CD56+ cells cannot adapt to chondrogenic
environment in vitro. In future, we would like to pursue analysis of in vivo
chondrogenic differentiation of PDGFRa+ cells in detail.
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FUNCTIONALLY DISTINCT MESENCHYMAL STEM CELL SUBSETS FROM
THE HUMAN SYNOVIUM
F. Gullo, Jr., C. De Bari, Sr.. Univ. of aberdeen, Aberdeen, United Kingdom;
Francesca Gullo and Cosimo De Bari Regenerative Medicine Group,
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Introduction: Osteoarthritis is the commonest joint condition character-
ized by a progressive breakdown of articular cartilage and other joint
tissues. Regenerative medicine offers the opportunity to promote joint
repair through biological tissue regeneration. Synovial mesenchymal stem
cells (MSCs) may represent an optimal source of chondrogenic cells for
joint resurfacing protocols However, until now, the deﬁnition of MSCs has
relied merely on the retrospective analysis of in vitro culture-expanded
cell populations. Moreover, MSCs undergo phenotypic rearrangements
during culture expansion becoming heterogeneous with spontaneous
differentiation and senescence. The resulting variability may affect the
outcome of clinical applications. The aim of this study is the identiﬁcation
of marker sets for consistent enrichment/puriﬁcation of MSCs from the
human synovium.
Methods: Synovial cells were isolated enzymatically from human
synovium specimens obtained after informed consent from patients
with osteoarthritis undergoing joint replacement. Flow cytometric
phenotypic analysis on freshly isolated and culture-expanded synovial
cells was performed using multiple combinations of conventional MSC
markers (CD106, CD271, CD73, CD90, CD13, CD81, CD105 and CD39) in
association with CD45, a pan-hematopoietic cell marker not expressed
by MSCs. Sorting was carried out using the FACS DiVA high speed
digital cell sorter. Sorted cell populations were assessed for clonoge-
nicity, kinetics of growth and chondro-osteogenic differentiation in
vitro.
Results: Analysis of the phenotype of culture-expanded synovial cells
showed that they were largely negative for CD45, as expected, and
positive in varying proportions for the MSC markers tested. After removal
from their natural environment, MSCs underwent phenotypic rear-
rangements during in vitro culture, losing the expression of LNGFR and
CD106 and acquiring other markers such as CD166 and CD146. After
culture expansion, two functionally distinct cell subsets revealed peculiar
abilities after sorting. The CD73posCD39neg fraction was signiﬁcantly
more clonogenic and proliferative but less chondrogenic and osteogenic
than the CD73posCD39pos fraction. However, no signiﬁcant differences in
terms of kinetics of growth, clonogenicity and chondro-osteogenic
potential were observed when the CD73posCD39neg and the
CD73posCD39pos cell subsets were puriﬁed directly from freshly isolated
synovial cell populations.
Conclusions: Our ﬁndings indicate that, in keeping with the literature,
culture conditions can profoundly inﬂuence MSC phenotype. MSCsundergo phenotypic and functional change due to the removal from their
niches and the use of chemical and physical growth conditions. Notably,
we provide evidence of existence of MSC subsets within culture-expanded
synovial cell populations, which display distinct chondro-osteogenic
potency. The puriﬁcation of MSCs with predictable biological activity will
allow the development of consistent MSC-based joint resurfacing proto-
cols for osteoarthritis.539
TYPE I COLLAGEN AND HEPARAN SULFATE SCAFFOLDS SUPPORT
HUMAN CHONDROGENESIS FOR CARTILAGE TISSUE ENGINEERING
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Purpose: Evaluate the proliferation and chondrogenic potential of
human bone marrow mesenchymal stem cells (hBM-MSCs) grown on
type I collagen and different concentrations of heparan sulfate (HS)
scaffolds.
Methods: hBM-MSCs and chondrocytes were cultured (150.000 cells/cm2)
on the scaffolds for 16 and 30 days. We performed 12 groups of study
(Table 1). hBM-MSCs were cultured in chondrogenic medium or DMEM
with 20% FBS plus 100 nM PTHrP. Chondrocytes were grown in DMEM
with 10% FBS plus 100 nM PTHrP. Chondrogenic differentiation was
conﬁrmed by histochemical and immunohistochemical analysis. Trans-
mission (TEM) and scanning (SEM) electronic microscopy were performed
to study the cell interior and the morphology.
Results: hBM-MSCs and chondrocytes were able to proliferate on type I
collagen and various concentrations of HS scaffolds, since cells showed
high percentages of positivity for PCNA proliferation marker (Fig. 1A).
Increased cell proliferation has been associated with a high rate of scaffold
degradation. The results indicated that hBM-MSCs proliferated better in
chondrogenic medium than in the usual growth medium (DMEM 20%).
The study groups with hBM-MSCs grown in chondrogenic medium +100
nM PTHrP, regardless the HS concentration, showed high percentage of
cells regarding the scaffold area (more than 80% after 16 days in culture
and more than 90% after 30 days in culture). Moreover, they also showed
high percentages of positivity for safranin O and type II collagen (Figure 1B
and C). Hematoxylin-eosin (H-E) (Fig. 1D) and Masson’s trichrome stain-
ings showed that cells formed aggregates and produced extracellular
matrix. By scanning electron microscopy (SEM) we studied the cell
morphology in culture over the biomaterials (Fig. 1E). Transmission elec-
tron microscopy (TEM) showed that cells had many ribosomes, large
number of lipid vacuoles and the accumulation of glycogen, characteristic
of the cells with a high activity (Fig. 1F).
Conclusions: Our data demonstrated that type I collagen and heparan
sulfate scaffolds were optimal for hBM-MSCs and chondrocyte growth and
that hBM-MSCs cultured over these scaffolds on chondrogenic medium
were able to differentiate to chondrocyte-like cells.
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Purpose: Osteoarthritis (OA) is a degenerative disease characterized by
the degradation of articular cartilage. Human bone marrow mesen-
chymal stem cells (BM-MSCs) have been presented as candidate cells for
cartilage tissue engineering due to their ability to undergo chondrogenic
differentiation after extensive expansion in vitro and stimulation with
various biomaterials in three-dimensional systems. Hyaluronic acid (HA)
is one of the major components of the hyaline cartilage and plays a key
role in maintaining chondrocytes function. PEPM [poly-(2-ethyl-2-pyr-
rolidone) methacrylate]-HA are semi-interpenetrated (SIPN) networks,
where this biopolymer is integrated as a building block for new
biocompatible therapeutic materials. This study is aimed at analyzing the
chondrogenic potential of BM-MSCs derived from OA patients, cultured
in PEPMHA hydrogels under hypoxia and normoxia environments,
simulating the physiological oxygen tension in cartilaginous regionsĂversus ambient air, respectively, as well as under static and semi-
dynamic conditions.
Methods: Human bone marrow MSCs isolated from OA patients, were
cultured in PEPMHA hydrogels, under hypoxia (5% pO2) or normoxia
environments (21% pO2), under static or semi-dynamic conditions (70
rpm). MSCs- only and chondrocytes (OA and normal) were seeded as
control. After 96 hours, cells’ viability was assessed using the alamar blue
assay. Cell-constructs were thereafter cultured for 21 days in a chondro-
genic differentiation medium, supplemented with the transforming
growth factor-b3 (TGF-b3), dexamethasone and retinoic acid. Histological
examination was performed using hematoxylin-eosin, alcian blue-PAS,
toluidine blue and safranin-O stainings, as well as immunohistochem-
istry analysis of types I, II and X collagen. Cell differentiation was
monitored by real-time PCR (types I, II collagen, aggrecan, MMP13 and
RUNX2). Fig.1
Results: BM- MSCs viability was assessed using the alamar blue assay.
After 96h seeding in PEPMHA hydrogels, under different conditions, cells
metabolic activity was altered although maintaining their viability (Figure
1) and therefore cell culture was performed for a longer period of time to
predict the suitability of this cell-construct for a cartilage tissue engi-
neering approach. After 21 days in a chondrogenic differentiation medium,
cells secreted an extracellular matrix incorporating types I, II collagen and
proteoglycans. Cells in normoxia, both under static or semi-dynamic
conditions, resulted in a more potent differentiation although in some
cases, MSCs were further differentiated to a premature hypertrophic state,
seen by the expression of type X collagen. Cells cultured under hypoxia
have shown a different behaviour, enabling the formation of a more stable
tissue, in the absence of hypertrophy.
Conclusions: MSCs derived from OA patients’ present a limitation for in
vitro chondrogenesis studies due to the imminent induction of a ﬁbro-
cartilaginous tissue. Culture in PEPMHA hydrogels alone was not
sufﬁcient to reverse this differentiation although from our results one
could speculate that hypoxia may delay terminal differentiation of
MSCs.
541
CHARACTERISATION OF OSTEOARTHRITIC-DERIVED CARTILAGE STEM
CELLS
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Purpose: Therapeutic treatments for articular cartilage repair are
limited and where they exist, such as Autologous Chondrocyte
Implantation (ACI), procedures result in variable outcomes. We
hypothesise that a major factor affecting the outcome of ACI and related
cell-based therapies is the source of cells used. We discovered that
cartilage derived stem cells from normal tissue have a high cellular
proliferative potential, maintain the chondrogenic phenotype in vitro
and demonstrate a restricted differentiation potential, such that they do
not express collagen type X. However, there is also a need to investigate
the biology of cartilage derived stem cells from osteoarthritic (OA)
joints and determine their potential for use in autologous cartilage
repair treatments. This work describes the isolation and character-
isation of OA derived cartilage stem cells.
Methods: Normal and osteoarthritic human cartilage samples were
obtained with relevant ethical approval. Cartilage biopsies were enzy-
matically digested and subjected to differential adhesion to ﬁbronectin.
Colonies generated from a single cell were selected and expanded with
population doubling (PD) data collated at each passage. At PD30 and PD50,
the b galactosidase assay for senescence and the bromodeoxyuridine
incorporation assay (BrDU) for proliferative index were performed on
monolayer cell cultures. Normal and OA derived stem cell lines were
subjected to Single Telomere Length Analysis (STELA) to determine
average telomere length.
Results: The results demonstrate that differential adhesion to ﬁbronectin
allows generation of OA-derived stem cell lines. However, percentages of
